AC Immune
ACIU
HK$18.45
Share price
-0.84%
Change (1 day)
-41.70%
Change (1 year)
Categories
Revenue for AC Immune (ACIU)
Revenue in 2025 (TTM): HK$0.25 Billion
According to AC Immune's latest financial reports the company's current revenue (TTM 
) is HK$0.26 Billion. In 2024 the company made a revenue of HK$0.24 Billion an increase over the revenue in the year 2023 that were of HK$0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AC Immune from 2015 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | HK$0.25 B | 3.63% |
| 2024 | HK$0.24 B | 81.65% |
| 2023 | HK$0.13 B | 340.77% |
| 2022 | HK$31.19 M | |
| 2021 | N/A | -100% |
| 2020 | HK$0.12 B | -85.51% |
| 2019 | HK$0.86 B | 1406.44% |
| 2018 | HK$57.56 M | -64.51% |
| 2017 | HK$0.16 B | -11.86% |
| 2016 | HK$0.18 B | -41.72% |
| 2015 | HK$0.31 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |